Adamax

Adamax is a synthetic nootropic peptide in the Semax family, derived from ACTH(4-7). It is a modified heptapeptide that combines the ACTH(4-7) core sequence with a novel extension designed to enhance CNS penetration and metabolic stability compared to earlier Semax compounds.

Adamax is studied for its ability to modulate BDNF (brain-derived neurotrophic factor) expression in hippocampal and cortical neurons, enhance dopaminergic neurotransmission, and provide neuroprotection against ischemic and oxidative injury. It is investigated in cognitive function models including memory formation, attention, and neuroprotection from stroke and hypoxia in preclinical research.

• BDNF upregulation and neurotrophin signaling in the hippocampus
• Dopaminergic neurotransmission enhancement studies
• Cognitive function, working memory, and attention research models
• Neuroprotection from cerebral ischemia and oxidative damage
• ACTH-derived peptide pharmacology and CNS penetration
• Comparison with Semax and other nootropic peptides

Dose levels referenced by the MVLabs peptide calculator, shown for research reference only:

Semax-family neuropeptide. Mainly intranasal. 14-day cycles.

Reconstitute the 10 mg vial in 10 mL of bacteriostatic water (1 mg/mL). Use the calculator for the exact units for your dose.

Research reference only — not dosing guidance for human use. Use the calculator for other vials or volumes.

Supplied as a lyophilized powder. Store at 2–8 °C on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.